A7061158
Avibactamsodium , 10mMinDMSO , 1192491-61-4
CAS NO.:1192491-61-4
Empirical Formula: C7H10N3NaO6S
Molecular Weight: 287.226
MDL number: MFCD28900719
| Pack Size | Price | Stock | Quantity |
| 1ml | RMB159.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >208°C (dec.) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated), Water (Slightly, Sonicated) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | H2O: 2mg/mL, clear |
| InChI | InChI=1/C7H11N3O6S.Na.H/c8-6(11)5-2-1-4-3-9(5)7(12)10(4)16-17(13,14)15;;/h4-5H,1-3H2,(H2,8,11)(H,13,14,15);;/t4-,5+;;/s3 |
| InChIKey | JKMUNBAKQJMVKG-NLZGLQCHNA-N |
| SMILES | C([C@@H]1CC[C@H]2N(OS(O)(=O)=O)C(=O)[N@@]1C2)(=O)N.[NaH] |&1:1,4,13,r| |
Description and Uses
Avibactam sodium (NXL-104), a diazabicyclooctanone compound, is currently the most favoured novel β-lactamase inhibitor. Compared with the three marketed β-lactamase inhibitors, NXL-104 has a long duration of action and reversible covalent binding to the enzyme, and does not induce β-lactamase production.
Avibactam (NXL104) is a novel β-lactamase inhibitor with a non-lactam structural scaffold. NXL104 irreversibly inhibits lactamase from Mycobacterium tuberculosis.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H319-H315-H335 |
| Precautionary statements | P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362 |






![tert-butyl N-[2-(aminooxy)ethyl]carbamate](https://img.chemicalbook.com/CAS/GIF/75051-55-7.gif)
![(1R,2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylicacid](https://img.chemicalbook.com/CAS/20180702/GIF/1174020-25-7.gif)